BioSig Technologies, Inc., following its merger with Streamex Exchange Corporation, has secured up to $1.1 billion in growth financing from a leading institutional investor. The transaction, led by Cantor Fitzgerald & Co., Clear Street LLC, and Needham & Company, LLC, aims to position BioSig as one of Nasdaq's largest public holders of gold bullion. This strategic move will support the launch of a gold-backed treasury management strategy and accelerate the company's efforts in real-world asset tokenization for the $142 trillion commodities market. With this financing, BioSig is set to transform global finance by integrating gold and commodities on-chain, enhancing liquidity, transparency, and accessibility.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.